Effects of Metabolic Medicine and Metabolic Surgery on Patient-Reported Outcomes Among Patients with Type 2 Diabetes
- 1 November 2022
- journal article
- research article
- Published by Mary Ann Liebert Inc in Metabolic Syndrome and Related Disorders
- Vol. 20 (9), 497-508
- https://doi.org/10.1089/met.2022.0039
Abstract
The assessment and management of patient-reported outcomes (PROs) is considered secondary to that of cardiometabolic outcomes. When assessed, health-related quality of life (HRQOL), a PRO, can yield pertinent information that cannot be obtained from cardiometabolic assessments. For instance, physical and mental distress can be quantified and treated. Moreover, treatment convenience and satisfaction can be gaged. Behavioral modification, bariatric surgery, and pharmacotherapy can improve PROs. Typically, HRQOL is responsive to changes in weight. Specifically, weight loss and weight gain are associated with positive and negative changes in quality of life, respectively. In addition, patient satisfaction can be influenced by glycemic control. Therefore, hypoglycemia and hyperglycemic episodes can negatively affect patient satisfaction. When managing type 2 diabetes (T2D), it is important to consider how therapies impact PROs. Generally, changes in clinical outcomes mirror changes in PROs. To best manage T2D, integrating the assessment of PROs with clinical outcomes is needed.Keywords
This publication has 120 references indexed in Scilit:
- Impact of Lifestyle Intervention and Metformin on Health-Related Quality of Life: the Diabetes Prevention Program Randomized TrialJournal of General Internal Medicine, 2012
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesThe New England Journal of Medicine, 2012
- Quality of life in type 2 diabetes mellitus after a very low calorie diet and exerciseEuropean Journal of Internal Medicine, 2012
- Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal studyHealth and Quality of Life Outcomes, 2012
- Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label studyDiabetic Medicine, 2011
- Changes in Health State Utilities With Changes in Body Mass in the Diabetes Prevention ProgramObesity, 2009
- Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily1Diabetic Medicine, 2009
- How Does Treatment Satisfaction Work?Diabetes Care, 2009
- Exercise Dose and Quality of LifeJAMA Internal Medicine, 2009
- Impact of a Weight Management Program on Health-Related Quality of Life in Overweight Adults With Type 2 DiabetesJAMA Internal Medicine, 2009